Should guidelines be rethought?

Largest real-world study of patients with multivessel disease reporting on 5-year outcome data.

CKD is a risk factor for hyperkalemia under spironolactone treatment.

Racial disparity is driven largely by poorer socioeconomic and health status.

There's a need for an easily referenced resource for prognostication.

Findings from a patient-level pooled analysis of 6 randomised controlled trials.

Findings from a recent analysis by BHF.

Investigators tested the effects of grapefruit juice on QT interval with the same methodology used by the pharmaceutical industry to test new drugs.

Post hoc pooled analysis of randomised controlled trials.

Results from an ADDITION-Cambridge trial.

Manchester pioneers digital health model combining technology and collaboration.

Patients slow to complete Timed Up and Go test likelier to require rehospitalization after discharge.

Meta-analysis of 14 studies.

Calcium-free phosphate binder is no safer than calcium-based agents.